Impaired in-vitro responses to IL-12 and IFN-γ in Iranian patients with Mendelian susceptibility to mycobacterial disease

Author(s): 
Parvaneh N1
Pourakbari B2
Rezaei N3
Omidvar A2
Sabouni F4
Mahmoudi S2
Khotaei G4
Mamishi S5
Abstract: 

INTRODUCTION:

Diagnosis of specific molecular defects of Mendelian susceptibility to mycobacterial diseases (MSMD) patients is important with respect to their clinical outcomes and their response to therapy. The aim of this study was to perform functional tests on blood samples of a group of patients who were suspected of having MSMD.

METHODS:

This study was performed on 11 cases who had mycobacterial infections and suspected MSMD. Whole blood cell culture was performed in presence of different stimulators. The supernatants were assayed for IFN-γ, IL-12p40 by ELISA method.

RESULTS:

All patients presented with complications of BCG vaccine in the form of localised lymphadenitis or disseminated BCG infection and chronic mycobacterial osteomyelitis. Infections with Salmonella species occurred in two patientsIn-vitro studies showed that 10 cases hadimpaired response to IL-12. However, the baseline levels of IL-12p40 were normal, while one of our patients may have a potential IFN-γ signalling defect or an IL-12p40 defect.

CONCLUSIONS:

Early detection of MSMD and commencing of appropriate combination therapy could prevent severe or even fatal complications of uncontrolled mycobacterial infections.

URL: 
https://www.ncbi.nlm.nih.gov/pubmed/?term=Impaired+in-vitro+responses+to+IL-12+and+IFN-%CE%B3+in+Iranian+patients+with+Mendelian+susceptibility+to+mycobacterial+disease

Contact Us

Research Center for Immunodeficiencies

Address: Pediatrics Center of Excellence, Children’s Medical Center Hospital, 62 Qarib St., Keshavarz Blvd., Tehran 14194, Iran

Research Center For immunodeficiency

Research Center For immunodeficiency